Pulmonary Reactions Associated with Amphotericin B and Leukocyte Transfusions

Stephen J. Forman, Gayle V. Robinson, Jeffrey L. Wolf, Wayne E. Spruce, Karl G. Blume, Michael W. Degregorio, William M.F. Lee, Curt A. Ries, Daniel G. Wright, Kay Robichaud, Philip A. Pizzo, Albert B. Deisseroth

Research output: Contribution to journalLetterpeer-review

13 Scopus citations


To the Editor: At the City of Hope National Medical Center, we have had substantial experience with the use of granulocytes and amphotericin B as part of our bone-marrow transplantation program for hematologic cancers. Our experience is considerably different from that reported by Wright and his co-workers in the May 14 issue.* Between May 1976 and May 1981, 95 patients with hematologic cancer underwent bone-marrow transplantation. The first 77 patients received prophylactic granulocyte support when the white-cell count fell below 500 per microliter, and they continued to receive this support until the count was above 500 per microliter (nine to.

Original languageEnglish (US)
Pages (from-to)584-585
Number of pages2
JournalNew England Journal of Medicine
Issue number10
StatePublished - Sep 3 1981

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Pulmonary Reactions Associated with Amphotericin B and Leukocyte Transfusions'. Together they form a unique fingerprint.

Cite this